• OPEN AN ACCOUNT
Indian Indices
Sensex
82,760.43 534.51
( 0.65%)
Global Indices
Nasdaq
49,202.49 377.42
(0.77%)
Dow Jones
6,910.52 51.77
(0.75%)
Hang Seng
57,337.44 511.74
(0.90%)
Nikkei 225
10,686.70 1.96
(0.02%)
Forex
USD-INR
90.87 0.15
(0.16%)
EUR-INR
107.26 0.37
(0.35%)
GBP-INR
122.73 0.47
(0.39%)
JPY-INR
0.59 0.00
(0.51%)

EQUITY - MARKET SCREENER

Vineet Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543298
INE505Y01010
23.0043581
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VINEETLAB
0
58.43
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

s&har technologies ltd
Ashoka Buildcon bags $45.28 Mln Intl road project in West Africa
Feb 16,2026
The company has been awarded the project from Ministry of Public Works, Liberia, for the upgradation of road stretches from Nrowkia (Sasstown Junction) to Barclayville, Nrowkia (Sasstown Junction) to Sasstown, and part of the Nrowkia (Sasstown Junction) to Nipleppo road in the Liberia.

The said project is valued at $ 45,276,621.07. The construction work is scheduled to be completed within a period of 24 months.

Ashoka Buildcon is engaged in the construction & maintenance of roads and supporting services to land support and operation of toll roads.

The company’s consolidated net profit zoomed 222.59% to Rs to Rs 2,111.41 crore in Q3 FY26 as against Rs 654.50 crore posted in Q3 FY25. Revenue from operations fell 23.47% YoY to Rs 1,827.33 crore in the quarter ended 31 December 2025.

The counter declined 4.26% to settle at Rs 151.75 on the BSE.